Genexine Market Cap

Genexine has a market cap or net worth of 217.85 billion as of June 16, 2025. Its market cap has decreased by -26.60% in one year.

Market Cap

217.85B

Enterprise Value

234.01B

Revenue

5.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,790.00

Market Cap Chart

Since September 15, 2009, Genexine's market cap has increased from 109.02B to 217.85B, an increase of 99.82%. That is a compound annual growth rate of 4.49%.

Market Cap History

Date	Market Cap	% Change
Jun 16, 2025	217.85B	-10.30%
Dec 30, 2024	242.86B	-40.82%
Dec 28, 2023	410.35B	-12.73%
Dec 29, 2022	470.21B	-67.78%
Dec 30, 2021	1,459.20B	-52.47%
Dec 30, 2020	3,069.93B	106.72%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.53T
Celltrion	35.56T
ALTEOGEN	20.60T
Yuhan	7,918.48B
SK Biopharmaceuticals	7,071.69B
HLB Co., Ltd.	6,912.47B
PharmaResearch	4,503.91B
Peptron	4,337.97B

Market Cap Rankings